fda semaglutide obesity U.S. | The FDA has approved a new higher dose (7.2 mg) of Wegovy ( semaglutide) injection, Wegovy HD, for weight loss and long-term weight FDA Approves Higher Dose Semaglutide

This coenzyme has attracted attention for anti-aging applications

The Precision Peptide Genetic Test available through PlexusDx analyzes key variants in your GLP1R gene and related metabolic pathways, revealing whether your system is naturally more or less responsive to GLP-1 signaling

$99 /mo plus the cost of membership Curbs appetite and reduces food cravings Average 1015% body weight loss in 6 months Convenient once-weekly self-injection Rx Most Popular Compounded Injectable Tirzepatide A dual-action, weekly GLP-1 injection for advanced, clinically proven weight loss results

Stevanato Group combines global manufacturing reach with an extensive product portfolio, allowing the company to support pharmaceutical partners with an end-to-end approach at scale